Feed TNDM
TN

Tandem Diabetes Care, Inc.

TNDM · NASDAQ

$16.28 -2.28% (-$0.38)
1M -26.86%
Market Cap $1.12B
P/E Ratio -
Div. Yield -
ROE 45.97%

Bulios Fair Price

$13.01

20.1% downside

Current Price

$16.28

Undervalued Fair Value Overvalued

According to Bulios Fair Price, TNDM is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Weak
3/9
Valuation
50 /100
Fair
P/B 8.56x
P/S 1.07x
P/FFO N/A
Growth
46 /100
Stable
Book val. growth 29.35%
Rev. growth 8.19%
FCF growth N/A
Profitability
20 /100
Weak
Op. margin 4.13%
Gross margin 56.01%
FCF margin 2.56%
Quality
11 /100
Poor
ROA 5.49%
ROIC 4.84%
Asset turnover 0.90x
Debt
23 /100
High
Int. coverage -6.42x
Debt/Equity 5.67x
Current ratio 3.18x
Stability
28 /100
Unstable
EPS volatility 103.17%
Beta 1.56x
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about TNDM
Online

About the company

Tandem Diabetes Care is a U.S.-based company specializing in the development and manufacturing of innovative devices for diabetes management. The company is particularly known for its technology in continuous glucose monitoring and insulin pumps, which assist patients with diabetes in managing their condition more effectively. Tandem Diabetes Care focuses on providing user-friendly and technologically advanced solutions that improve the quality of life for diabetics and make daily management of their treatment easier.

Sector

Healthcare

Industry

Medical - Devices

CEO

John F. Sheridan

Employees

2,500

Headquarters

San Diego

Upcoming events

05 NOV

Earnings

Upcoming earnings report

50d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.